Skip to main content
TXG logo

TXG · 10x Genomics, Inc. · Investor Relations

Track TXG — free
$51.80 -5.58 (-9.72%) At close · Nov 20 Play latest call Q3 2026 earnings call transcript
Market Cap
$6.81B
Shares
131.53M
Volume · Nov 20 3.23M Avg daily vol (3M) 3.36M

Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Recent news

Date Headline
2026-11-16 10x Genomics Expands Global Research in Blood-Based Diagnostics for Autoimmune Disease with Two New Collaborations
2026-11-10 Shanghai Precision Diagnostics and Fudan University Shanghai Cancer Center Launch Breast Cancer Biomarker Study Using 10x Genomics' Xenium Platform
2026-11-05 10x Genomics Reports Third Quarter 2026 Financial Results
2026-11-02 10x Genomics Launches Sentira Single Cell, A New Agentic AI Experience for Chromium Analysis
2026-10-27 10x Genomics to Participate in the 2026 Jefferies Global Healthcare Conference
2026-10-13 10x Genomics to Report Third Quarter 2026 Financial Results on November 5, 2026
2026-10-07 10x Genomics Announces New Collaboration to Advance Single Cell and Spatial Applications Across Solid Tumors and Blood Cancers
2026-09-29 10x Genomics Announces Sentira, a New Computational Platform to Turn Complex Biological Data Into Experimental Conclusions
2026-09-29 10x Genomics Begins Global Shipments of Atera, Putting Unprecedented Spatial Biology Capabilities in Researchers' Hands
2026-08-28 10x Genomics Wins Patent Infringement Verdict Against Parse Biosciences
2026-08-06 10x Genomics Reports Second Quarter 2026 Financial Results
2026-07-29 10x Genomics and Lausanne University Hospital Collaborate to Advance Research in Diagnostic Applications of Single Cell and Spatial Technologies for Cancer Care
2026-07-15 10x Genomics to Report Second Quarter 2026 Financial Results on August 6, 2026
2026-06-17 10x Genomics and Cleveland Clinic Collaborate to Advance Research in Diagnostic Applications of Single Cell and Spatial Technologies in Patients with Bladder Cancer
2026-06-09 10x Genomics Acquires Proteintech Genomics, a Division Within Proteintech Group
2026-05-07 10x Genomics Reports First Quarter 2026 Financial Results
2026-04-29 10x Genomics to Participate in the BofA Securities 2026 Healthcare Conference
2026-04-19 10x Genomics Introduces Atera, a New Platform to Redefine How Biology is Measured and Understood
2026-04-15 10x Genomics to Report First Quarter 2026 Financial Results on May 7, 2026
2026-03-25 Bioptimus Announces STELA: The World’s Largest Clinically Linked Spatial Biology Atlas, Alongside Key Partners 10x Genomics and Broad Clinical Labs
2026-02-19 10x Genomics to Participate in the 46th Annual TD Cowen Health Care Conference
2026-02-12 10x Genomics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Outlook for 2026
2026-02-04 PharosAI and 10x Genomics Partner to Transform Cancer Research with AI and Spatial Biology
2026-01-26 BioTuring and 10x Genomics Announce Strategic Collaboration to Streamline Single Cell and Spatial Data Analysis

SAN DIEGO, Calif. — January 26, 2026 — BioTuring and 10x Genomics, Inc . (Nasdaq: TXG), a leader in single cell and spatial biology, today announced a strategic collaboration to streamline and accelerate the path from data generation to biological insight for single cell and spatial research workflows. The collaboration connects 10x’s Chromium single cell platform and Xenium and Visium spatial platforms with BioTuring’s advanced analytical ecosystem. This integration supports more efficient exploration, visualization and interpretation of high-complexity single cell and spatial multiomics data by enabling a more seamless, end-to-end workflow that extends the downstream capabilities of 10x’s software ecosystem. As advances in single cell and spatial technologies enable larger and increasingly complex multimodal experiments, some researchers face challenges related to fragmented analysis workflows, access to scalable computational resources and analysis

2026-01-22 10x Genomics to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026

10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced it will report financial results for the fourth quarter and full year ended December 31, 2025 after market close on Thursday, February 12, 2026. The company will host a public conference call and live webcast for analysts and investors beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its results, business developments and outlook. The news release with the financial results will be accessible from the company's website prior to the conference call. Interested parties may access a live webcast of the fireside chat on the "Investors" section of the company's website at: https://investors.10xgenomics.com/ . The webcast will be archived and available for replay for at least 45 days after the event. About 10x Genomics 10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated research solutions

Past events

Date Event Type
2026-11-17 2026 Jefferies Global Healthcare Conference Conference
2026-11-05 10x Genomics Third Quarter 2026 Earnings Conference Call Earnings call
2026-08-06 10x Genomics Second Quarter 2026 Earnings Conference Call Earnings call
2026-06-04 2026 Annual Meeting of Stockholders Shareholder meeting
2026-05-14 BofA Securities 2026 Healthcare Conference Conference
2026-05-07 10x Genomics First Quarter 2026 Earnings Conference Call Earnings call
2026-03-03 TD Cowen 46th Annual Health Care Conference Conference
2026-02-12 10x Genomics Fourth Quarter and Full Year 2025 Earnings Conference Call Earnings call
2026-01-12 44th Annual J.P. Morgan Healthcare Conference Conference
2025-11-18 Wolfe Research Healthcare Conference 2025 Conference
2025-11-06 10x Genomics Third Quarter 2025 Earnings Conference Call Earnings call
2025-09-10 Morgan Stanley 23rd Annual Global Healthcare Conference Conference
2025-08-07 10x Genomics Second Quarter 2025 Earnings Conference Call Earnings call
2025-06-03 2025 Annual Meeting of Stockholders Shareholder meeting
2025-05-13 BofA Securities 2025 Healthcare Conference Conference
2025-05-08 10x Genomics First Quarter 2025 Earnings Conference Call Earnings call
2025-03-04 TD Cowen 45th Annual Health Care Conference Conference
2025-02-12 10x Genomics Fourth Quarter and Full Year 2024 Earnings Conference Call Earnings call
2025-01-13 43rd Annual J.P. Morgan Healthcare Conference Conference
2024-11-19 Wolfe Research 2024 Healthcare Conference Conference
2024-10-29 10x Genomics Third Quarter 2024 Earnings Conference Call Earnings call
2024-09-04 Morgan Stanley 22nd Annual Global Healthcare Conference Conference
2024-08-08 10x Genomics Second Quarter 2024 Earnings Conference Call Earnings call
2024-06-11 2024 Annual Meeting of Stockholders Shareholder meeting
2024-05-14 BofA Securities 2024 Healthcare Conference Conference

Source: https://investors.10xgenomics.com/overview/default.aspx

Key facts CIK 1770787 CUSIP 88025U109 13F (30d) 482 filings 441 filers Visit website Investor relations